Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?

To: Daveyk who wrote (747)	3/10/2000 1:13:00 PM
From: Bosco	Read Replies (2) \| Respond to of 1298

Hi Dave - me too <G>. But seriously, we know the biotech is weak b/c of the tremendous gain in the last 2 months and people are locking in profits. Also, we know Friday is not likely a good day for the weak sector. So, I can say these are the two short term negatives. However, biotech is real. It takes a lot of time and efforts, therefore, there was a letdown in the late 80s. Time has changed. Biotech has a lot more tools and techniques unheard of even a few years ago, like biochips! So, I would like to think this is a quantum leap. Just think of the technical force of a decade of basing! As far as CEGE is concerned, I think she is like a baby got thrown out with the bath water! Also, one should blame those folks who risk their capital a year ago and decide to cash in their 10 baggers or even 20 baggers. I am late, but not too late. Stockwise, she may be rich relative to a year ago. Storywise, she has not yet begun the 2nd chapter! best, Bosco